HCRT and Cataplexy: Type 1: excessive daytime sleepiness, an irrepressible need to sleep or lapses into sleep (for at least three months), low levels of hypocretin (also known as orexin, a neuropeptide with a role in the regulation of arousal and sleep states) [79,80,81], cataplexy, and specific paraclinical features [76].